Boston Scientific Corp
BSX
$103.14+0.18 (+0.17%)
Aug 8, 2025, 4:00 PM
Financials
| 52Week High | 108.94 | 52Week Low | 73.61 |
| Beta | 0.64 | Current Ratio Annual | 1.08 |
| Current Ratio Quarterly | 1.37 | Gross Margin TTM | 68.30 |
| Market Cap | 152.83B | Net Profit Margin TTM | 13.55 |
| Operating Margin TTM | 17.02 | Price To Book | 6.82 |
| Price To Earnings TTM | 60.98 | Price To Free Cash Flow TTM | 43.87 |
| Price To Sales TTM | 8.26 | Quick Ratio Annual | 0.59 |
| Quick Ratio Quarterly | 0.76 | Return On Assets TTM | 6.30 |
| Return On Equity TTM | 11.51 | Return On Investment TTM | 7.61 |
| Revenue Growth3Y | 12.10 | Revenue Growth5Y | 9.30 |
| Revenue Growth Quarterly Yoy | 22.84 | Revenue Growth TTMYoy | 21.45 |
| Revenue Per Share TTM | 12.38 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 1561 | 201 | 131 | 630 | 525 | 175 | 1.33B | $126.51B |
| Jun 30, 2025 | 945 | 68 | 42 | 391 | 273 | 144 | 189.84M | $18.45B |
| Change | 616(39%) | 133(66%) | 89(68%) | 239(38%) | 252(48%) | 31(18%) | 1.14B(86%) | $108.06B(85%) |